Mersana Therapeutics Stock Forward View - Price Action Indicator
| MRSN Stock | USD 29.08 0.18 0.62% |
Mersana Stock outlook is based on your current time horizon. Although Mersana Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Mersana Therapeutics' systematic risk associated with finding meaningful patterns of Mersana Therapeutics fundamentals over time.
As of today the rsi of Mersana Therapeutics' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (2.94) | EPS Estimate Current Year (14.31) | EPS Estimate Next Year (11.11) | Wall Street Target Price 30.75 | EPS Estimate Current Quarter (0.89) |
Using Mersana Therapeutics hype-based prediction, you can estimate the value of Mersana Therapeutics from the perspective of Mersana Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Mersana Therapeutics using Mersana Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Mersana using crowd psychology based on the activity and movement of Mersana Therapeutics' stock price.
Mersana Therapeutics Short Interest
An investor who is long Mersana Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Mersana Therapeutics and may potentially protect profits, hedge Mersana Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 12.2293 | Short Percent 0.0119 | Short Ratio 0.79 | Shares Short Prior Month 53.8 K | 50 Day MA 23.9768 |
Mersana Relative Strength Index
Mersana Therapeutics Hype to Price Pattern
Investor biases related to Mersana Therapeutics' public news can be used to forecast risks associated with an investment in Mersana. The trend in average sentiment can be used to explain how an investor holding Mersana can time the market purely based on public headlines and social activities around Mersana Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Mersana Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Mersana Therapeutics.
Mersana Therapeutics Implied Volatility | 0.37 |
Mersana Therapeutics' implied volatility exposes the market's sentiment of Mersana Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Mersana Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Mersana Therapeutics stock will not fluctuate a lot when Mersana Therapeutics' options are near their expiration.
Mersana Therapeutics after-hype prediction price | USD 26.71 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Prediction based on Rule 16 of the current Mersana contract
Based on the Rule 16, the options market is currently suggesting that Mersana Therapeutics will have an average daily up or down price movement of about 0.0231% per day over the life of the 2026-02-20 option contract. With Mersana Therapeutics trading at USD 29.08, that is roughly USD 0.006725 . If you think that the market is fully incorporating Mersana Therapeutics' daily price movement you should consider acquiring Mersana Therapeutics options at the current volatility level of 0.37%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-02-20 Mersana Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Mersana Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Mersana Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Mersana Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Mersana Therapeutics' open interest, investors have to compare it to Mersana Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Mersana Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Mersana. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Mersana Therapeutics Additional Predictive Modules
Most predictive techniques to examine Mersana price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mersana using various technical indicators. When you analyze Mersana charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.42) | (0.42) |
| Check Mersana Therapeutics Volatility | Backtest Mersana Therapeutics | Information Ratio |
Mersana Therapeutics Trading Date Momentum
| On February 05 2026 Mersana Therapeutics was traded for 29.08 at the closing time. The top price for the day was 30.39 and the lowest listed price was 28.78 . There was no trading activity during the period 0.0. Lack of trading volume on February 5, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.62% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Mersana Therapeutics to competition
Mersana Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mersana Therapeutics stock to make a market-neutral strategy. Peer analysis of Mersana Therapeutics could also be used in its relative valuation, which is a method of valuing Mersana Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Mersana Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Mersana Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mersana Therapeutics shares will generate the highest return on investment. By undertsting and applying Mersana Therapeutics stock market strength indicators, traders can identify Mersana Therapeutics entry and exit signals to maximize returns.
Mersana Therapeutics Risk Indicators
The analysis of Mersana Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Mersana Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting mersana stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.16 | |||
| Semi Deviation | 2.27 | |||
| Standard Deviation | 26.03 | |||
| Variance | 677.76 | |||
| Downside Variance | 17.13 | |||
| Semi Variance | 5.16 | |||
| Expected Short fall | (7.83) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Mersana Therapeutics
The number of cover stories for Mersana Therapeutics depends on current market conditions and Mersana Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Mersana Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Mersana Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Mersana Therapeutics Short Properties
Mersana Therapeutics' future price predictability will typically decrease when Mersana Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Mersana Therapeutics often depends not only on the future outlook of the potential Mersana Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mersana Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.9 M | |
| Cash And Short Term Investments | 134.6 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Will Biotechnology sector continue expanding? Could Mersana diversify its offerings? Factors like these will boost the valuation of Mersana Therapeutics. Expected growth trajectory for Mersana significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mersana Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (13.95) | Revenue Per Share | Quarterly Revenue Growth (0.13) | Return On Assets | Return On Equity |
Investors evaluate Mersana Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Mersana Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Mersana Therapeutics' market price to deviate significantly from intrinsic value.
Understanding that Mersana Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mersana Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Mersana Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.